Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Treatment decision algorithms, a hope for the diagnosis of tuberculosis in children. Photo Credit: Stuart Tibaweswa /Epicentre
Press release
Press release |
19 March 2025
Tuberculosis

MSF calls for sustained investments to fight against tuberculosis in children

4 min
Maria Atonio, 43-years-old farmer from Macomia, shows Anti-retro-viral medication after visiting MSF’s Clinic in Nanga, Mozambique. Photo Credit: Martim Gray Pereira/MSF
Press release
Press release |
14 February 2025
HIV/AIDS
United States of America

Uncertainty around PEPFAR program puts millions of people at risk

6 min
Christophe Perrin, TB Advocacy Pharmacist for MSF's Access Campaign presents on Access to Medicines and Diagnostics at the Union World Conference on Lung Health Photo credit: MSF

Christophe Perrin, TB Advocacy Pharmacist for MSF's Access Campaign presents on Access to Medicines and Diagnostics at the Union World Conference on Lung Health

Press release
Press release |
13 November 2024
Tuberculosis

MSF calls for equitable access to TB drugs and diagnostics in first-ever plenary session on access at the TB Union Conference

3 min
MSF and TB activists take stage at TB Union conference 2024 to call on Cepheid and Danaher to reduce the price of GeneXpert tests to US$5 Photo credit: MSF

MSF and TB activists take stage at TB Union conference 2024 to call on Cepheid and Danaher to reduce the price of GeneXpert tests to US$5

Press release
Press release |
12 November 2024
Tuberculosis

MSF and global TB activists take stage at annual TB conference

2 min
Insulin pen for people with diabetes Photo credit: Jinane Saad
Press release
Press release |
11 November 2024
Diabetes

Ahead of World Diabetes Day, pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi must make insulin pens available at $1 per pen

5 min
MSF protests at International AIDS Conference asking for price reduction for CAB-LA and LEN-LA.
Press release
Press release |
17 October 2024
Diagnostics

‘Time for $5’ campaign to deliver 206,937 signatures to US corporation Danaher in Washington, DC, demanding a $5 price for their medical tests

4 min
Vaishnavi, a 7-year-old DRTB (Drug Resistant​ Tuberculosis) patient interacts with Prachi, an MSF nurse as her mother Vishaka holds her.​ Photograph by Prem Hessenkamp
Press release
Press release |
15 October 2024
Tuberculosis

MSF calls for urgent action as governments and donors are failing children with TB

4 min
Insulin pens, provided by MSF to diabetes type I patients below 15 years old. Photo credit: Jinane Saad/MSF
Press release
Press release |
26 September 2024
Diabetes

MSF calls out Novo Nordisk for its double standard approach to diabetes, as corporation plans to halt supply of human insulin pens

5 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury